Ibrutinib Intermediate 1-Boc-3-hydroxypiperidine 143900-44-1 

Ibrutinib Intermediates (S)-1-Boc-3-hydroxypiperidine 143900-44-1: Product name: (S)-1-Boc-3-hydroxypiperidine Cas Number: 143900-44-1 Moculer formula:C10H19NO3 Moculer weight: 201.263 Appearance: White powder Assay(By HPLC): ≥99.0% Ibrutinib (USAN, also known as PCI-32765 and marketed under the name Imbruvica) is an anticancer drug targeting B-cell malignancies. It is an orally-administered, selective and covalent inhibitor of the enzyme Bruton's tyrosine kinase (BTK). Ibrutinib was developed by Pharmacyclics, Inc and Johnson & Johnson's Janssen Pharmaceutical division for additional B-cell malignancies including diffuse large B-cell lymphoma and multiple myeloma. Our productions of Ibrutinib Intermediates: Ibrutinib Intermediates (S)-1-Boc-3-hydroxypiperidine 143900-44-1: Package & Shipping: 1. Preferentially DHL or FedEx for quantity less than 50KG; Air shipping fo…